EII Capital Management’s Bio-Rad Laboratories Class A BIO Stock Holding History

EII Capital Management’s Portfolio BIO Stock Details BIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	–	Sell	-19,150	Closed	-$2.17M	–	156
2014 Q3	$2.17M	Sell	19,150 -10,150	-35%	-$1.2M	0.14%	70
2014 Q2	$3.51M	Buy	29,300 +150	+0.5%	+$18.3K	0.07%	51
2014 Q1	$3.73M	Sell	29,150 -600	-2%	-$76.9K	0.08%	50
2013 Q4	$3.68M	Buy	29,750 +3,000	+11%	+$366K	0.09%	50
2013 Q3	$3.15M	Hold	26,750	–	–	0.08%	51
2013 Q2	$3M	Buy	+26,750	New	+$3.14M	0.07%	52

Other funds holding BIO

Americafirst Capital Management Roseville, California $74M AUM 13.49% 1-Year Est. Return

Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return

Levin Capital Strategies New York $1.32B AUM 28.11% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

NWQ Investment Management Company Los Angeles, California $2.22B AUM 6.84% 1-Year Est. Return

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return